Amgen Inc. Shareholders' Equity for the year ending December 31, 2024: USD 5.88 B

Amgen Inc. Shareholders' Equity is USD 5.88 B for the year ending December 31, 2024, a -5.70% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Amgen Inc. Shareholders' Equity for the year ending December 31, 2023 was USD 6.23 B, a 70.23% change year over year.
  • Amgen Inc. Shareholders' Equity for the year ending December 31, 2022 was USD 3.66 B, a -45.36% change year over year.
  • Amgen Inc. Shareholders' Equity for the year ending December 31, 2021 was USD 6.70 B, a -28.79% change year over year.
  • Amgen Inc. Shareholders' Equity for the year ending December 31, 2020 was USD 9.41 B, a -2.73% change year over year.
Key Data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory